Raymond James Financial
COYA icon

Raymond James Financial’s Coya Therapeutics COYA Stock Holding History

Raymond James Financial’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46K Buy
11,673
+693
+6% +$3.24K ﹤0.01% 5132
2025
Q4 		$63.7K Buy
+10,980
New +$66.7K ﹤0.01% 4989
2025
Q3 		– Sell
-1,980
Closed -$11.4K – 5332
2025
Q2 		$11.4K Buy
+1,980
New +$11.5K ﹤0.01% 5871

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Raymond James Financial's COYA Position: Q1 2026 in Review

Raymond James Financial increased its Coya Therapeutics (COYA) stake by 6.3% in Q1 2026, buying an estimated $3.24K and bringing the position to 11,673 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #5132.

Raymond James Financial first reported a position in COYA in Q2 2025 and has held it in 3 quarters since. The position peaked at $63.7K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Raymond James Financial held 11,673 shares of Coya Therapeutics worth $46K as of Q1 2026.
  • Raymond James Financial bought 693 Coya Therapeutics shares in Q1 2026, an estimated $3.24K.
  • Coya Therapeutics made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5132 holding.
  • Raymond James Financial first reported a position in Coya Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Raymond James Financial's Coya Therapeutics position peaked at $63.7K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.